Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 9 Dec 2004 |
| Genmab, HuMax-CD20 Shows Favorable Clinical Responses in NHL | 5 Dec 2004 |
| Genmab, announces Encouraging Efficacy Data from Humax-EGFr Phase I/II Trial in Head and Neck Cancer | 1 Dec 2004 |
| Genmab, Grant of Warrants in Genmab A/S | 1 Dec 2004 |
| InvestorService: Genmab, to Present at ING 4th Annual European Healthcare Conference | 30 Nov 2004 |